Cidara Therapeutics Inc (CDTX)
11.77
-0.21
(-1.75%)
USD |
NASDAQ |
May 01, 16:00
11.77
0.00 (0.00%)
After-Hours: 20:00
Cidara Therapeutics Max Drawdown (5Y): 95.11% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 95.11% |
March 31, 2024 | 95.11% |
February 29, 2024 | 95.11% |
January 31, 2024 | 95.11% |
December 31, 2023 | 95.11% |
November 30, 2023 | 95.11% |
October 31, 2023 | 95.11% |
September 30, 2023 | 95.11% |
August 31, 2023 | 95.11% |
July 31, 2023 | 95.11% |
June 30, 2023 | 95.11% |
May 31, 2023 | 95.11% |
April 30, 2023 | 95.11% |
March 31, 2023 | 95.11% |
February 28, 2023 | 95.11% |
January 31, 2023 | 95.11% |
December 31, 2022 | 95.11% |
November 30, 2022 | 95.11% |
October 31, 2022 | 95.11% |
September 30, 2022 | 95.11% |
August 31, 2022 | 95.11% |
July 31, 2022 | 95.11% |
June 30, 2022 | 95.11% |
May 31, 2022 | 95.11% |
April 30, 2022 | 92.76% |
Date | Value |
---|---|
March 31, 2022 | 92.76% |
February 28, 2022 | 92.76% |
January 31, 2022 | 92.76% |
December 31, 2021 | 92.76% |
November 30, 2021 | 92.76% |
October 31, 2021 | 92.76% |
September 30, 2021 | 92.76% |
August 31, 2021 | 92.76% |
July 31, 2021 | 92.76% |
June 30, 2021 | 92.76% |
May 31, 2021 | 92.76% |
April 30, 2021 | 92.76% |
March 31, 2021 | 92.76% |
February 28, 2021 | 92.76% |
January 31, 2021 | 92.76% |
December 31, 2020 | 92.76% |
November 30, 2020 | 92.76% |
October 31, 2020 | 92.76% |
September 30, 2020 | 92.76% |
August 31, 2020 | 92.76% |
July 31, 2020 | 92.76% |
June 30, 2020 | 92.76% |
May 31, 2020 | 92.76% |
April 30, 2020 | 92.76% |
March 31, 2020 | 92.76% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
90.67%
Minimum
May 2019
95.11%
Maximum
May 2022
93.62%
Average
92.76%
Median
Aug 2019
Max Drawdown (5Y) Benchmarks
Johnson & Johnson | 27.36% |
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -37.66 |
Beta (5Y) | 1.109 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 91.38% |
Historical Sharpe Ratio (5Y) | -0.2769 |
Historical Sortino (5Y) | -0.7271 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.13% |